Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-01-09
1998-06-23
Grimes, Eric
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530324, A61K 3857, C07K 1481
Patent
active
057705682
ABSTRACT:
Peptides having essentially the sequence of bovine pancreatic trypsin inhibitor (aprotinin) wherein one or more of the amino acids at positions 15, 16, 17, 18, 34, 39 and 52 are replaced by any naturally occurring amino acid produced by recombinant DNA technology, process, expression vector and recominant host therefor and pharmaceutical use thereof. Such peptides being useful as therapeutic agents in diseases connected with the presence of excessive amounts of proteinases.
REFERENCES:
patent: 4595674 (1986-06-01), Tschesche et al.
patent: 5032573 (1991-07-01), Auerswald et al.
patent: 5118668 (1992-06-01), Auerswald et al.
patent: 5164482 (1992-11-01), Ebbers et al.
patent: 5618915 (1997-04-01), Bjorn et al.
Tschesche et al. May 27, 1987, Biochemica. et Biophysica Octo 913: 97-101.
Dayhoff et al. 1972, Atlas of Protein Sequence and Structure 5:89-99.
Tschesche et al. 1983, Adv. Exp. Med. Biol. 156A:329-337.
Hochstrasser et al. 1985, Biol. Chem. Hoppe-Seyler 366:473-478.
Biochemistry, vol. 16, No. 8, Apr. 19, 1977, pp. 1531-1541, Tan et al.
The Journal of Biological Chemistry, vol. 260, No. 21, Sep. 25, 1986, pp. 11451-11455, E. Fiovetti et al.
EMBO Journal, vol. 5, No. 12, 1986, pp. 3219-3225, B. von Wilcken-Bergmann et al.
ADV. Exp. Med. Biol., 1983, pp. 329-337; H. Tschesche et al.
Journal of Biological Chemistry, vol. 261, No. 15, Jun. 5, 1986, pp. 7115-7118, C. Berman Marks et al.
Bowie et al., 1990, Science 247: 1306-1310.
Dayhoff et al., 1972, Atlas of Protein Sequence and Structure 5:89-99.
Tschesche et al., 1983, Adv. Exp. Med. Biol. 156A:329-337.
Tschesche et al., 1987, Biochimica et Biophysica Acta 913:97-101.
Wunderer et al., 1981, Methods in Enzymology 80:816-820.
Wachter et al., 1980, Febs Lett. 119(1) :58-62.
Kato, I. 1979, Fed. Proc. 38:832, Abstract No. 3168.
Hochstrasser et al., 1985, Biol. Chem. Hoppe-Seyler, vol. 366:473-478.
Strydom et al., 1981, Hoppe-Seyler's Physiol. Chem. Bd. 362:1377-1384.
Kingston et al., 1986, Biochem J. 233, pp. 443-450.
Biol. Chem. Hoppe-Seyler, vol. 369, Suppl., pp. 27-35, May 1988.
Biochimica et Biophysica Acta 913 (1987), pp. 97-101, Elsevier.
Biol. Chem. Hoppe-Seyler, vol. 368, pp. 1413-1425, Oct. 1987.
Arzneim.-Forsch./Drug Res. 33(I), No. 4 (1983) Fritz et al.-Aprotinin, pp. 479-494.
J. Biochem., vol. 76, No. 4, 1974, pp. 721-733.
The Journal of Biological Chemistry, vol. 260, No. 21, Issue of Sep., pp. 11451-11455, 1985.
Cold Spring Harbor Symposia on Quantitative Biology, vol. LII, 1987, T.E. Creighton et al., pp. 511-519.
J. Biochem., vol. 101, No. 5, 1987, pp. 1297-1306.
FEBS Letters, vol. 119, No. 1, Sep. 1980, pp. 58-62.
TIBS 15, Nov. 1990, Elsevier Science Publishers Ltd. (UK), pp. 435-439.
Biol. Chem. Hoppe-Seyler, vol. 369, pp. 157-163, Mar. 1988.
PROTEINS: Structure, Function, and Genetics 9:1-11 (1991), Struthers et al.
Eur. J. Biochem, 202, pp. 95-99 (1991).
Journal of Protein Chemistry, vol. 10, No. 2, 1991, pp. 245-251.
Eur. J. Biochem. 153, pp. 647-654 (1985).
Nature, vol. 338, 6 Apr. 1989, pp. 518-520.
Biochem. J. (1986), vol. 233, pp. 442-450, Kingston et al.
APROT18.XLS, Dr. J. Beunink (PH-P/VE Bio), Jul. 14, 1993, Sequence alignment of different kunitz-type proteinase inhibitors.
Strydom et al. 1981 Hoppe-Seyler's 2. Physiol. Chem. Bd. 362, S. 1377-1384.
Kato I. 1979, Fed. Proc. 38:832, Abstract No. 3168.
Wachter et al.1980 FEBS Letters 119(1):58-62.
Wunderer et al. 1981. Methods in Enzymology 80:816-820.
Kingston et al. 1986, Biochem J. 233:443-450.
Bowie et al. 1990. Science 247: 1306-1310.
Auerswald Ernst-August
Bruns Wolfgang
Horlein Dietrich
Reinhardt Gerd
Schnabel Eugen
Bayer Aktiengesellschaft
Grimes Eric
LandOfFree
Variants of bovine pancreatic trypsin inhibitor produced by reco does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Variants of bovine pancreatic trypsin inhibitor produced by reco, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Variants of bovine pancreatic trypsin inhibitor produced by reco will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1394787